Price, D. Et Al. 2024. Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS. PRAGMATIC AND OBSERVATIONAL RESEARCH , 1-16.

Price, D., Henley, W., Cancado, J. E. D., Fabbri, L. M., Kerstjens, H. A. M., Papi, A., ... Roche, N.(2024). Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS. PRAGMATIC AND OBSERVATIONAL RESEARCH , 1-16.

Price, David Et Al. "Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS," PRAGMATIC AND OBSERVATIONAL RESEARCH , 1-16, 2024

Price, David Et Al. "Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS." PRAGMATIC AND OBSERVATIONAL RESEARCH , pp.1-16, 2024

Price, D. Et Al. (2024) . "Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS." PRAGMATIC AND OBSERVATIONAL RESEARCH , pp.1-16.

@article{article, author={David Price Et Al. }, title={Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS}, journal={PRAGMATIC AND OBSERVATIONAL RESEARCH}, year=2024, pages={1-16} }